HDL particle number measured on the Vantera®, the first clinical NMR analyzer

Article ID	Journal	Published Year	Pages	File Type
10817838	Clinical Biochemistry	2015	8 Pages	PDF

Abstract

The performance characteristics, as well as the primary tube sampling procedure for specimen analysis on the Vantera® Clinical Analyzer, suggest that the HDL-P assay is suitable for routine clinical applications.

Keywords

FDA LDL particle number LDL-P IDL LOQ CLIA VLDL CLSI HDL-P HDL HDL-C LDL-C CIM nuclear magnetic resonance high-density lipoprotein clinical laboratory standards institute Clinical Laboratory Improvement Amendments cardiovascular disease ion mobility NMR limit of blank CVD Food and Drug Administration Coefficient of Variation NMR spectroscopy confidence intervals Lob Lod very low density lipoprotein Intermediate density lipoprotein Low-density lipoprotein LDL limit of detection limit of quantitation

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry

Preview

HDL particle number measured on the Vantera®, the first clinical NMR analyzer

Authors

Steven P. Matyus, Paul J. Braun, Justyna Wolak-Dinsmore, Amy K. Saenger, Elias J. Jeyarajah, Irina Shalaurova, Suzette M. Warner, Timothy J. Fischer, Margery A. Connelly,